MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1
Lijuan Sun(Qinghai University), Jiayin Li, Zeyu Lin(Sun Yat-sen University), Yandan Yao(Sun Yat-sen University), Cuilin Pan, W. Chen(Sun Yat-sen University), Qiang Liu(Second Affiliated Hospital of Zhejiang University), Mei Yang(Sun Yat-sen University), Ling Lin(Huazhong University of Science and Technology), Erwei Song(Sun Yat-sen University), Wei Zhang(Sun Yat-sen University), Bodu Liu(Sun Yat-sen University)
Cited by 248
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
|Molecular Cancer|2011|700
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
|Clinical Cancer Research|2009|435
Inflammation in atherosclerosis: pathophysiology and mechanisms
|Cell Death and Disease|2024|342